Captrust Financial Advisors Zoetis Inc. Transaction History

Captrust Financial Advisors

$34.2 Billion
Q4 2024

A detailed history of Captrust Financial Advisors transactions in Zoetis Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 98,701 shares of ZTS stock, worth $16.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

98,701

Previous 80,225 23.03%

Holding current value

$16.3 Million

Previous $15.7 Million 2.6%

% of portfolio

0.05%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$162.24 - $194.42 $3 Million - $3.59 Million	18,476 Added 23.03%	98,701 $16.1 Million
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $369,148 - $420,270	-2,139 Reduced 2.6%	80,225 $15.7 Million
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $862,178 - $1.06 Million	-5,924 Reduced 6.71%	82,364 $14.3 Million
Q1 2024 May 15, 2024	SELL	$165.67 - $199.94 $1.39 Million - $1.68 Million	-8,419 Reduced 8.71%	88,288 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $19,687 - $26,011	130 Added 0.13%	96,707 $19.1 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $2.73 Million - $3.15 Million	16,362 Added 20.4%	96,577 $16.8 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $238,674 - $276,179	-1,483 Reduced 1.82%	80,215 $13.8 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $3.11 Million - $3.74 Million	-21,368 Reduced 20.73%	81,698 $13.6 Million
Q4 2022 Feb 15, 2023	BUY	$131.14 - $157.47 $599,965 - $720,425	4,575 Added 4.65%	103,066 $15.1 Million
Q3 2022 Nov 16, 2022	BUY	$148.29 - $182.55 $656,776 - $808,513	4,429 Added 4.71%	98,491 $14.6 Million
Q2 2022 Aug 23, 2022	SELL	$155.97 - $200.09 $1.05 Million - $1.35 Million	-6,725 Reduced 6.67%	94,062 $16.2 Million
Q2 2022 Aug 16, 2022	BUY	$155.97 - $200.09 $519,380 - $666,299	3,330 Added 3.42%	100,787 $17.3 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $2.2 Million - $2.83 Million	12,108 Added 14.19%	97,457 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $424,181 - $540,995	2,190 Added 2.63%	85,349 $20.8 Million
Q3 2021 Nov 16, 2021	SELL	$189.29 - $209.69 $65,683 - $72,762	-347 Reduced 0.42%	83,159 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$155.9 - $187.99 $2.57 Million - $3.1 Million	16,514 Added 24.65%	83,506 $15.6 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $1.07 Million - $1.26 Million	-7,415 Reduced 9.97%	66,992 $10.6 Million
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $251,626 - $279,308	-1,602 Reduced 2.11%	74,407 $12.3 Million
Q3 2020 Nov 17, 2020	SELL	$137.1 - $165.37 $1.66 Million - $2 Million	-12,094 Reduced 13.73%	76,009 $12.5 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $628,990 - $801,018	-5,620 Reduced 6.0%	88,103 $12.1 Million
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $996,836 - $1.56 Million	10,758 Added 12.97%	93,723 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $8.88 Million - $10.2 Million	76,405 Added 1164.71%	82,965 $11.1 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $3,939 - $4,495	-35 Reduced 0.53%	6,560 $817,000
Q2 2019 Aug 13, 2019	BUY	$97.98 - $114.28 $313,242 - $365,353	3,197 Added 94.08%	6,595 $748,000
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $27,975 - $34,529	343 Added 11.23%	3,398 $342,000
Q4 2018 Feb 13, 2019	BUY	$79.28 - $95.27 $40,591 - $48,778	512 Added 20.13%	3,055 $261,000
Q3 2018 Nov 15, 2018	SELL	$83.5 - $93.23 $1,586 - $1,771	-19 Reduced 0.74%	2,543 $233,000
Q2 2018 Aug 13, 2018	BUY	$79.9 - $89.2 $103,550 - $115,603	1,296 Added 102.37%	2,562 $218,000
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $98,826 - $117,041	-1,382 Reduced 52.19%	1,266 $103,000
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $165,372 - $190,372	2,615 Added 7924.24%	2,648 $191,000
Q3 2017 Feb 16, 2018	BUY	$59.73 - $65.4 $1,971 - $2,158	33	33 $2,000

Others Institutions Holding ZTS

# of Institutions

2,055

Shares Held

419M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Zoetis Inc. Transaction History